NeuDreamer
Boston, Massachusetts, United States
We are a US-registered company specializing in neuromodulation, focused on the early prevention and treatment of Alzheimer's Disease (AD), Major Depressive Disorder (MDD), Insomnia, and other Neurology Diseases. Our globally patented technology, Rhythmic Deep Brain Low-Field Transcranial Magnetic Stimulation (rDMS), is integrated into a mature product. We utilize a closed-loop intervention to help our users sleep better. Combined with our sleep monitoring pad, this innovative approach is designed to maximize stimulation in memory consolidation and AD prevention, with promising results already observed. We are currently in the Phase 2A clinical trial stage and are seeking further collaborative research opportunities globally, especially in North America.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2023
- Website
- www.neudreamer.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of NeuDreamer?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now